Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-22-000104

Chief Medical Officer gave up 2,783 shares (to pay taxes)

  • Chief Medical Officer acquired 9,375 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Gheuens Sarah Chief Medical Officer 2022-12-23 Option exercise +9,375 18,388 D: show line 1 in the form
Gheuens Sarah Chief Medical Officer 2022-12-28 Shares withheld for taxes −2,783 $28.48 $79,260 15,605 D: show line 2 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Gheuens Sarah Chief Medical Officer 2022-12-23 Option exercise · Restricted stock units −9,375 0 D: show line 3 in the form
Loading xslF345X03/wf-form4_167226148971361.xml…